Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Patient-reported outcome measures are important tools for capturing the patient experience and enhancing the patient-physician interaction. IPC has developed and executed a global study designed to evaluate the practical usefulness of the Psoriasis Symptom Inventory (PSI) in clinical settings. The inventory is a validated, 8-item measure developed to assess the severity of patient-reported psoriasis signs and symptoms.

For the study, patients with psoriasis were asked to fill out a questionnaire asking them about 8 symptoms: itch, redness, scaling, burning, stinging, cracking, flaking and pain. The PSI was tested in 8 clinical settings: Utah, Missouri, and Connecticut in the United States; Quebec, Canada; Manchester, England; Nijmegen, the Netherlands; Porto Alegre, Brazil; and Santiago, Chile. 

Findings from this study will inform the dermatology community on the utility of the PSI in global clinical practice settings. Ultimately, understanding patient perspectives of psoriasis symptoms will lead to patient-focused disease management.

IPC Board Member Dr. Bruce Strober, University of Connecticut Health Center, who led the study, presented a poster detailing the research at the American Academy of Dermatology annual meeting in March. The poster is available at This study was sponsored and funded in conjunction with Amgen. Study results will be presented later in the year.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.